Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Clinical and visual outcomes after secondary implantation of a sulcus ciliary additional IOL in pseudophakic eyes

Search Title by author or title

Session Details

Session Title: Pseudophakic IOLs: Toric, Multifocal, Accommodative

Session Date/Time: Monday 09/10/2017 | 14:30-16:00

Paper Time: 15:16

Venue: Room 4.1

First Author: : F.Le Guyader FRANCE

Co Author(s): :    T. Raffray   J. Bertholom   T. Louesdon   A. Massot   A. Pineau        

Abstract Details

Purpose:

to review our cases after secundary implantation of a novel add-on IOL for sulcus implantation in pseudophakic eyes

Setting:

Cendre Vision Bretagne, Vannes, France

Methods:

All cases implanted with the same additional lens (Reverso, Cristalens, France) implanted in the ciliary sulcus of pseudophakic patients were reviewed: indications, visual acuity, refraction, side effects were screened.

Results:

eight out of 13 patients wished a multifocal lens after their cataract surgery. One, for high astigmatism. Four, high residual hyperopia due to preoperative biometry error or presbyopia were motivating the secondary IOL. Except for one patient with multifocal IOL in the capsular bag, they all benefited of a +3D diffractive addition. Mean uncorrected and distance-corrected visual acuities were 0.09±0.09 and 0.05±0.05 in LogMAR and all patients achieved distance visual acuity better than 0.3LogMAR. Near visual acuity was better or equal to LogMAR 0.18 in all cases. The postoperative spherical equivalent is 0.04±0.09D. No complication was noticed.

Conclusions:

Visual outcomes and refractive accuracy were satisfactory. No surgical complication or adverse events were observed in our series. These encouraging outcomes may motivate surgeons to propose a reversible solution to presbyopia of monofocal pseudophakia

Financial Disclosure:

travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to previous